Clinical Trials Logo

Hernia clinical trials

View clinical trials related to Hernia.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 9

NCT ID: NCT01860469 Not yet recruiting - Clinical trials for Patients Undergoing Ventral or Inguinal Hernia Repair

Reducing Mesh Infections in Open Hernia Repairs

Start date: June 2013
Phase: Phase 2/Phase 3
Study type: Interventional

Soaking meshes in a vancomycin solution just prior to their use in open hernia repairs will decrease rates of mesh infection

NCT ID: NCT01731509 Not yet recruiting - Clinical trials for Congenital Diaphragmatic Hernia

Early FETO for Severe Congenital Diaphragmatic Hernia

Start date: June 2014
Phase: Phase 2
Study type: Interventional

Congenital diaphragmatic hernia (CDH) is associated high mortality and morbidity, mainly in those cases with severe forms where there are extremely reduced lung volumes, liver herniation and decreased abnormal pulmonary vascularization. Fetal endoscopic tracheal occlusion performed between 26 and 30 weeks (standard FETO) has been shown to increase fetal pulmonary size and vascularity, and to improve infant survival in isolated severe CDH. Fetal pulmonary response followed FETO can be used to predict outcome and is dependent on the size of the fetal lung prior to the procedure. We hypothesize that performing an earlier FETO, between 22-24 weeks, fetuses with severe form of CDH will have a better fetal pulmonary response and higher chance of surviving.

NCT ID: NCT01069055 Not yet recruiting - Postoperative Pain Clinical Trials

Comparison of Lornoxicam and Paracetamol for Pre-emptive Intravenous Analgesia for Elective Inguinal Hernia Repair

Start date: February 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether lornoxicam or paracetamol is more effective in providing pre-emptive analgesia for adult patients undergoing elective unilateral inguinal hernia repair under general anesthesia.

NCT ID: NCT00480142 Not yet recruiting - Clinical trials for Elective Laproscopic Cholecystectomy

Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy

Start date: July 2007
Phase: Phase 4
Study type: Interventional

A Prospective Double Blind RCT: Controlled Release Oxycodone 10 mg On a 12 h Dosing Schedule Started With The Premedication ,Placebo Controlled Study,On Post Operative Analgesia Management in Laparoscopic Cholecystectomy and Laparoscopic Bilateral Inguinal Hernia (BIH). CRO is indicated for the management of moderate to severe pain when a continuous,around the clock analgesic is needed for an extended period of time.Its safety and efficacy in the first 12-24 hours post operative has not been established.